Scholars Central

Conference abstractPublished 6 Dec 2017

The development of antiviral agent for Hepatitis B virus

Authors: Hong Sik Han

University of Science and Technology, Korea

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Infection of Heapatitis B virus (HBV) was widely known for causing 680,000 deaths annually worldwide and 240 million individuals suffer from chronic HBV infection. It is a key cause of fatal liver cirrhosis and hepatocellular carcinoma. Even if there are several treatment options for chronic HBV infections, they also have some disadvantages. Nucleot(s)ide analogues (NAs), such as telbivudine, lamivudine, adefovir, tenofovir, entecavir, can be used as rapid effects on HBV polymerase and reverse transcriptase activity. But, it give rise to problems of drug-resistant HBV strains and the requirement of the patient for essentially lifelong treatment. Thus, it needs to be considered about developing drug which target different stages. The HBV nucleocapsid is an essential element that can encapsulate the HBV pgRNA, as well as HBV polymerase. Because of its critical roles in viral assembly, it has been attracted as a target of HBV. Among many classes, represnetative two inhibitors are belived as SBAs (sulfamoylbenzamides) and HAP (heteroaryldigydropyrimidines). Due to outstanding similarity and difference between both of their chemical structures and binding poses in same pocket, it is attracting us to structure-based drug design and synthesis for HBV inhibition. With aim to improve the anti-HBV activity, we found some activity compound.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedicinal Chemistry
  • SubjectChemistry
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Hong Sik Han”